Oxford Immunotec Global plc Appoints Richard Wenstrup, MD, as Chief Medical Officer
July 24, 2017 at 06:30 pm IST
Oxford Immunotec Global PLC announced the appointment of Richard Wenstrup, MD, as Chief Medical Officer. Dr. Wenstrup brings to Oxford Immunotec more than 20 years of clinical leadership experience, including over a decade within the diagnostics industry. Most recently, Dr. Wenstrup served as Executive Vice President, Chief Medical Officer, for Myriad Genetics Inc.